Stefanos Theoharis
Chief Executive Officer OneChain Immunotherapeutics
Seminars
Wednesday 25th February 2026
Industry Leaders Fireside Chat: Navigating Europe’s Cell Therapy Landscape Amid Investment Pressures, Novel Approaches, & Opportunities for Patient Access
8:30 am
- Discuss how investment headwinds are shaping company strategies and what it takes to sustain progress in Europe
- Highlight the most promising scientific advances, including novel indications, armouring strategies, and in-vivo approaches
- Explore how patient access models, from point-of-care manufacturing to evolving reimbursement pathways, can unlock future growth
Wednesday 25th February 2026
Advancing CAR-T Therapies with Real-World Clinical Data to Drive Next- Generation Development
4:00 pm
- Share up-to-date clinical data from the ongoing CAR-T program in T-cell leukaemia
- Discuss the latest development from OneChain’s next-generation CAR-T products across hematologic malignancies and solid tumours
- Explore advantages and opportunities with OneChain’s allogeneic iPSC-derived gamma delta T-cell platform
New Data
